|
Pharmaceutical Products – Delivery Of Medicinal Products As Part Of Drug Programs. Group 1 - Bevacizumab,Group 2 - Dexamethasoneum,Group 3 - Faricimab,Group 4 - Entekawir,Group 5 - Tenofovir Disoproxil,Group 6 - Glecaprevir +Pibrentasvir,Group 7 - Sofosbuvirum + Velpatasvirum + Voxilaprevirum,Group 8 -Adalimumabum,Group 9 - Bimekizumab,Group 10 - Certolizumab,Group 11 - Etanercept,Group 12 - Ixekizumab,Group 13 - Secukinumab,Group 14 - Tyldrakizumab,Group 15 - Ustekinumab,Group 16 - Abrocitinib,Group 17 - Varicytynib,Group 18 - Tralokinumab,Group 19 - Upadacitinibum,Group 20 - Anifrolumabum,Group 21 - Omalizumab,Group 22 - Adalimumabum,Group 23 - Adalimumabum,Group 24 - Lebrikizumabum,Group 25 -Glatiramer Acetates,Group 26 - Interferons Beta 1B,Group 27 -Aflibercept,Group 28 - Ozanimod,Group 29 -Botulinum Toxin,Group 30 -Botulinum Toxin,Group 31 - Human Immunoglobulin,Group 32 - Rizankizumab,Group 33 - Guselkumab,Group 34 - Brolucizumab,Group 35 - Natalizumab
|
